Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
This grant funds the discovery and development of small molecule drugs for disorders of the nervous system.
About this program
The Blueprint Neurotherapeutics Network (BPN) grant supports innovative research aimed at the discovery and development of small molecule therapeutics for neurological disorders. This initiative is designed to foster collaboration among researchers, institutions, and industry partners to accelerate the translation of scientific discoveries into effective treatments. The program encourages the submission of proposals that focus on the entire drug development process, from initial discovery through preclinical and clinical development phases. Eligible applicants include academic institutions, nonprofit organizations, and for-profit companies engaged in drug discovery and development. The grant aims to support projects that demonstrate a clear pathway to clinical application, addressing significant unmet medical needs in the field of neurology. By providing funding and resources, the BPN seeks to enhance the efficiency and success rate of bringing new therapies to market for patients suffering from neurological disorders.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and for-profit companies engaged in drug discovery and development.